前收市價 | 167.25 |
開市 | 166.64 |
買盤 | 164.11 x 100 |
賣出價 | 164.26 x 100 |
今日波幅 | 160.38 - 166.64 |
52 週波幅 | 125.82 - 335.91 |
成交量 | |
平均成交量 | 868,556 |
市值 | 11.496B |
Beta 值 (5 年,每月) | 1.00 |
市盈率 (最近 12 個月) | 55.84 |
每股盈利 (最近 12 個月) | 2.94 |
業績公佈日 | 2024年5月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 236.83 |
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.